The healthcare economy is poised for transformation. As pressures in other sectors of the economy place even greater pressure on healthcare in America, the market is especially ripe for new business models and innovative solutions.  These solutions must reduce the cost of delivering healthcare to our citizenry while improving the quality of care and patient outcomes for all.  Now, more than ever, there is a rising demand for new business solutions that deliver real value for each healthcare dollar. Key value drivers include:

    • adoption and proliferation of evidence-based medicine;
    • an orientation towards prevention and wellness;
    • active engagement of the consumer/patient in the prevention and treatment process;
    • better organization, coordination and management of care;
    • elimination of medical errors; and,
    • data and technology-driven solutions to enhance the clinical and financial value of services received.

Psilos invests in essential services, information technologies and medical technologies that rise to the challenges of the new and evolving healthcare economy. We are specifically looking for innovative products and services that:

    • reduce healthcare system costs;
    • enhance quality of care; and,
    • align the economic and clinical incentives of patients, payers and providers.

David VanAvermaete, President and CEO, discusses VeraLight’s mission to help stem the tide of the worldwide diabetes epidemic through early detection, thus enabling initiation of therapies that can prevent diabetes or reduce its complications.

Diabetes is a global epidemic that has enormous health, social, and economic implications. Because early diabetes detection is critical to addressing this epidemic, VeraLight is developing the SCOUT DS system. SCOUT DS is intended to be the first non-invasive diabetes screening system designed to provide a more accurate and convenient method for screening type 2 diabetes and pre-diabetes based on the presence of advanced glycation endproduct biomarkers found in skin. Unlike current screening methods, a SCOUT DS test is intended to require no blood draw, no fasting and no waiting for a lab result.